February 9, 2023
Nephron Research Ranked #1 By Institutional Investor
February 7, 2023
Next Big Things: Why Pulsed Field Ablation Will Revolutionize the Treatment of AF
February 7, 2023
Protected: Understanding the PFA Competitive Landscape – Feb. 7th – REPLAY
February 3, 2023
Protected: Nephron Expert Call: Humira Biosimilar Launch Dynamics – Feb. 3rd – REPLAY
January 20, 2023
Protected: Nephron KOL Call on Lab/Dx Industry Updates – Jan. 19th – REPLAY
January 17, 2023
Protected: Nephron Research JPM 2023 Conference Takeaways – REPLAY
January 13, 2023
TWIPE? This Week in Physician Enablement – San Fran Edition
January 5, 2023
Protected: CRC Screening KOL Call Post-ECLIPSE for EXAS/GH – REPLAY
December 21, 2022
Protected: Nephron Research 2023 Outlook Call – Dec. 20 – REPLAY
December 13, 2022
Protected: BDO Bioprocessing Update – Dec. 8th – REPLAY
November 23, 2022
Protected: Bioprocessing Industry KOL Call – Nov. 22 – REPLAY
November 18, 2022
Protected: Obamacare USPSTF Litigation Call with Josh Booth – 11/16 – REPLAY
November 16, 2022
Protected: Bioprocessing Market Update – Nov. 16th – REPLAY
November 1, 2022
Protected: Opioid Litigation: The Plaintiffs’ View of Pharmacy Liability – 10/31 – REPLAY
October 25, 2022
Nephron’s MedTech Data Insights – Recovery Scorecard